{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:16:38Z","timestamp":1764587798156},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000003044","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T12:33:51Z","timestamp":1457613231000},"page":"e3044","source":"Crossref","is-referenced-by-count":13,"title":["Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers"],"prefix":"10.1097","volume":"95","author":[{"given":"Jos\u00e9 M.","family":"Porcel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aureli","family":"Esquerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Mart\u00ednez-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bielsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonieta","family":"Salud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-65-20210226","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.arbres.2013.11.007","article-title":"Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses","volume":"50","author":"Porcel","year":"2014","journal-title":"Arch Bronconeumol"},{"key":"R2-65-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejim.2010.03.011","article-title":"Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients","volume":"21","author":"Porcel","year":"2010","journal-title":"Eur J Intern Med"},{"key":"R3-65-20210226","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccm.2012.11.002","article-title":"Pleural fluid biomarkers: beyond the Light criteria","volume":"34","author":"Porcel","year":"2013","journal-title":"Clin Chest Med"},{"key":"R4-65-20210226","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"R5-65-20210226","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/bioinformatics\/bti456","article-title":"Sample size for FDR-control in microarray data analysis","volume":"21","author":"Jung","year":"2005","journal-title":"Bioinformatics"},{"key":"R6-65-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Machine Learning"},{"key":"R7-65-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1157\/13115113","article-title":"Approach to the methodology of classification and regression trees","volume":"22","author":"Trujillano","year":"2008","journal-title":"Gac Sanit"},{"key":"R8-65-20210226","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1378\/chest.126.6.1757","article-title":"Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions","volume":"126","author":"Porcel","year":"2004","journal-title":"Chest"},{"key":"R9-65-20210226","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.04.00010504","article-title":"Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions","volume":"25","author":"Iglesias","year":"2005","journal-title":"Eur Respir J"},{"key":"R10-65-20210226","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1183\/09031936.00127807","article-title":"High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation","volume":"33","author":"Sheen","year":"2009","journal-title":"Eur Respir J"},{"key":"R11-65-20210226","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/sj.bjc.6605607","article-title":"Pleural fluid analysis of lung cancer vs benign inflammatory disease patients","volume":"102","author":"Kremer","year":"2010","journal-title":"Br J Cancer"},{"key":"R12-65-20210226","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2004.01.176","article-title":"Significant accumulations of cathepsin B and prolylendopeptidase in inflammatory focus of delayed-type hypersensitivity induced by Mycobacterium tuberculosis in mice","volume":"316","author":"Kakegawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-65-20210226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-1843.2003.00521.x","article-title":"A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion","volume":"9","author":"Chierakul","year":"2004","journal-title":"Respirology"},{"key":"R14-65-20210226","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1159\/000087672","article-title":"C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis","volume":"72","author":"Garcia-Pachon","year":"2005","journal-title":"Respiration"},{"key":"R15-65-20210226","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.rmed.2006.09.019","article-title":"Acute phase markers for the differentiation of infectious and malignant pleural effusions","volume":"101","author":"Kiropoulos","year":"2007","journal-title":"Respir Med"},{"key":"R16-65-20210226","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.trsl.2015.04.006","article-title":"Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis","volume":"165","author":"Nguyen","year":"2015","journal-title":"Transl Res"},{"key":"R17-65-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7314\/APJCP.2014.15.1.363","article-title":"CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R18-65-20210226","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1515\/BC.2007.139","article-title":"Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma","volume":"388","author":"Chee","year":"2007","journal-title":"Biol Chem"},{"key":"R19-65-20210226","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MCP.0000000000000167","article-title":"Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma","volume":"21","author":"Creaney","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"R20-65-20210226","doi-asserted-by":"crossref","first-page":"11694","DOI":"10.18632\/oncotarget.3429","article-title":"High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis","volume":"6","author":"Thomas","year":"2015","journal-title":"Oncotarget"},{"key":"R21-65-20210226","doi-asserted-by":"crossref","first-page":"e800","DOI":"10.1097\/MD.0000000000000800","article-title":"Diagnostic pitfalls of discriminating lymphoma-associated effusions","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R22-65-20210226","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5152\/pb.2012.14","article-title":"Proteomics in pleural effusions","volume":"6","author":"S\u00e1nchez-Otero","year":"2012","journal-title":"Plevra B\u00fclteni"},{"key":"R23-65-20210226","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1074\/mcp.M114.045914","article-title":"In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery","volume":"14","author":"Liu","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"R24-65-20210226","first-page":"S2223","article-title":"Proteomic pilot study of tuberculosis pleural effusion","volume":"26","author":"Zhang","year":"2015","journal-title":"Biomed Mater Eng"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:19:37Z","timestamp":1620958777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603080-00065"}},"subtitle":["A Predictive Multivariate Model"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003044","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}